blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1360293

EP1360293 - SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.06.2008
Database last updated on 13.11.2024
Most recent event   Tooltip13.06.2008Application deemed to be withdrawnpublished on 16.07.2008  [2008/29]
Applicant(s)For all designated states
Molecular Engines Laboratories
20, rue Bouvier
75011 Paris / FR
[2003/46]
Inventor(s)01 / TELERMAN, Adam
6, rue du Pré-aux-Clercs
F-75007 Paris / FR
02 / AMSON, Robert
10, rue Gay-Lussac
F-75005 Paris / FR
03 / TUIJNDER, Marcel
Moestuinstraat 2
B-2800 Mechelen / BE
04 / SUSINI, Laurent
5 rue du Trèfle
F-95160 Montmorency / FR
 [2004/04]
Former [2003/46]01 / TELERMAN, Adam
6, rue du Pré-aux-Clercs
F-75007 Paris / FR
02 / AMSON, Robert
10, rue Gay-Lussac
F-75005 Paris / FR
03 / TUIJNDER, Marcel
Moestuinstraat 2
B-2800 Mechelen / BE
04 / SUSINI, Laurent
3, allée Maurice Ravel
F-93160 Noisy-le-Grand / FR
Representative(s)Texier, Christian, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [2003/46]Texier, Christian, et al
Cabinet Régimbeau 20, rue de Chazelles
75847 Paris cedex 17 / FR
Application number, filing date02708409.413.02.2002
[2003/46]
WO2002FR00543
Priority number, dateFR2001000192513.02.2001         Original published format: FR 0101925
[2003/46]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO02064731
Date:22.08.2002
Language:FR
[2002/34]
Type: A2 Application without search report 
No.:EP1360293
Date:12.11.2003
Language:FR
The application published by WIPO in one of the EPO official languages on 22.08.2002 takes the place of the publication of the European patent application.
[2003/46]
Search report(s)International search report - published on:EP06.03.2003
ClassificationIPC:C07K14/47, C07K16/18, C12N15/63, C12N15/10, C12Q1/68, G01N33/53, A61K48/00, A61K39/395, A61K38/17, A01K67/027
[2007/35]
CPC:
C07K14/47 (EP,US); A61P25/00 (EP); A61P31/12 (EP);
A61P35/00 (EP); A01K2217/05 (EP,US); C12N2799/021 (EP,US)
Former IPC [2003/46]C12N15/12, C07K14/47, C07K16/18, C12N15/63, C12N15/10, C12Q1/68, G01N33/53, A61K48/00, A61K39/395, A61K38/17, A61P35/00, A61P31/12, A61P25/00, A01K67/027
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/46]
TitleGerman:SEQUENZEN DIE AN DER TUMORUNTERDRÜCKUNG, TUMORUMKEHRUNG, APOPTOSIS, UND/ODER VIRUSRESISTENZ BETEILIGT SIND, UND IHRE VERWENDUNG ALS ARZNEIMITTEL[2007/37]
English:SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES[2003/46]
French:SEQUENCES IMPLIQUEES DANS LES PHENOMENES DE SUPPRESSION TUMORALE, REVERSION TUMORALE, APOPTOSE ET/OU RESISTANCE AUX VIRUS ET LEUR UTILISATION COMME MEDICAMENTS[2003/46]
Former [2003/46]SEQUENZE DIE IN DER TUMORUNTERDRÜCKUNG, TUMORUMKEHRUNG, APOPTOSIS, UND/ODER VIRUSRESISTENZ BETEILIGT SIND, UND IHRE VERWENDUNG ALS ARZNEIMITTEL
Entry into regional phase01.09.2003National basic fee paid 
01.09.2003Designation fee(s) paid 
01.09.2003Examination fee paid 
Examination procedure10.09.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.09.2003Examination requested  [2003/46]
09.12.2004Despatch of a communication from the examining division (Time limit: M04)
06.04.2005Reply to a communication from the examining division
21.07.2005Despatch of a communication from the examining division (Time limit: M04)
30.11.2005Reply to a communication from the examining division
28.04.2006Despatch of a communication from the examining division (Time limit: M04)
01.08.2006Reply to a communication from the examining division
21.08.2006Despatch of a communication from the examining division (Time limit: M04)
12.12.2006Reply to a communication from the examining division
10.09.2007Communication of intention to grant the patent
22.01.2008Application deemed to be withdrawn, date of legal effect  [2008/29]
26.02.2008Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2008/29]
Fees paidRenewal fee
01.09.2003Renewal fee patent year 03
21.02.2005Renewal fee patent year 04
20.02.2006Renewal fee patent year 05
26.02.2007Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
29.02.200807   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO9412881  (HOCHSTRASSER DENIS F [CH], et al) [X] 1-4 * abstract * [Y] 1-30;
 [Y]FR2782085  (FONDATION JEAN DAUSSET CEPH [FR]) [Y] 1-30 * abstract * * page 1, line 5 - line 10 * * page 2, line 16 - line 25 * * page 3, line 22 - line 26 * * page 5, line 4 - page 6, line 21 * * page 7, line 19 - line 22 *;
 [A]US5952179  (CHINNADURAI GOVINDASWAMY [US]) [A] 2 * column A *;
 [X]  - NCI-CGAP, "tz08a06.x1 NCI_CGAP_Ut1 Homo sapiens cDNA clone IMAGE:2287954 3' similar to gb:X16064 TRANSLATIONALLY CONTROLLED TUMOR PROTEIN (HUMAN);, mRNA sequence", EM_EST, EMBL, (19990427), Database accession no. AI635631, URL: EBI, XP002209854 [X] 1,2 * the whole document *
 [X]  - NCI-CGAP, "tr64c07.x1 NCI_CGAP_Pan1 Homo sapiens cDNA clone IMAGE:2223084 3' similar to gb:X16064 TRANSLATIONALLY CONTROLLED TUMOR PROTEIN (HUMAN);, mRNA sequence", EM_EST, EMBL, (19990329), Database accession no. AI567685, URL: EBI, XP002209855 [X] 1,2 * the whole document *
 [A]  - LI ET AL, "A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (19971121), vol. 272, no. 47, ISSN 0021-9258, pages 29403 - 29406, XP002159206 [A] 2 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.272.47.29403
 [DA]  - BRENNER ET AL., "In vitro cloning of complex mixtures of DNA on microbeads: Physical separation of differentially expressed cDNAs", PROCEEDINGS OF THE NATINAL ACADEMY OF SCIENCES USA, (20000215), vol. 97, no. 4, pages 1665 - 1670, XP002183229

DOI:   http://dx.doi.org/10.1073/pnas.97.4.1665
 [A]  - SALESIOTIS A N ET AL, "IDENTIFICATION OF NOVEL GENES FROM STOMACH CANCER CELL LINES BY DIFFERENTIAL DISPLAY", CANCER LETTERS, NEW YORK, NY, US, (1995), vol. 91, ISSN 0304-3835, pages 47 - 54, XP002917863 [A] * abstract * * page 51, column R *

DOI:   http://dx.doi.org/10.1016/0304-3835(95)03717-B
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.